In AF, both structural and electrophysiological remodeling of the atrial myocardium occurs, leading to increased susceptibility to arrhythmias, thus perpetuating the condition ("AF begets AF"). The most prominent alteration is a shortening in action potential duration (APD), 2 which is believed to favor reentry of excitation being largely attributable to a reduction of L-type Ca 2ϩ current (I Ca,L ). 3, 4 Although this reduces the Ca 2ϩ influx per excitation, the rate of excitation is increased, ie, the atrial heart rate during AF. There is evidence suggesting that cellular Ca 2ϩ overload may occur in AF and might play a role in its pathogenesis. [5] [6] [7] [8] [9] Interestingly, acute rapid pacing induces increased cellular Ca 2ϩ loading in atrial myocytes from sinus rhythm dogs. 10 Elevation of diastolic [Ca 2ϩ ] through increased sarcoplasmic reticulum (SR) Ca 2ϩ spark frequency is regarded as an arrhythmogenic mechanism in failing ventricular myocardium: Ca 2ϩ sparks are believed to participate as crucial events in the initiation and propagation of Ca 2ϩ waves in cardiac myocytes and the elimination of cytosolic Ca 2ϩ via the Na ϩ /Ca 2ϩ exchanger (NCX) generates a depolarizing current (transient inward current, I TI ), which can give rise to delayed afterdepolarizations (DADs). 11 Increased Ca 2ϩ influx attributable to the increased rate of I Ca,L activation in AF may contribute to the increased diastolic Ca 2ϩ levels, although I Ca,L itself is reduced. In addition, other causes for elevated diastolic Ca 2ϩ levels are possible. One major mechanism in failing ventricular myocardium is a Ca 2ϩ leak from the SR via the ryanodine receptor type 2 (RyR2). In fact, increased SR Ca 2ϩ spark frequency has been observed in atrial myocytes from human AF patients, as well as increased RyR2 open probability in an AF animal model. 12, 13 The cause for this SR Ca 2ϩ leak remained unknown. It is suggested that hyperphosphorylation of the RyR2 is a mechanism causing "leakiness" of the channel. 14 -16 In AF, compartmentalization of kinase/phosphatase activity is presumed to occur and upregulation of inhibitor-1 is believed to reduce protein phosphatase (PP)1 activity at the SR, leading to enhanced phosphorylation levels of RyR2. 13, 17, 18 PP activity along the sarcolemma appears to be increased. Phospholamban (PLB) phosphorylation levels have been described both as increased as well as reduced. 17, 18 Mice in a model with hyperphosphorylation of PLB and RyR2 developed AF and other arrhythmias. 19 Ca 2ϩ /calmodulin-dependent protein kinase (CaMK)II is a serine/threonine protein kinase that regulates several Ca 2ϩ -handling proteins (eg, RyR2, PLB, L-type Ca 2ϩ channel) and has been shown to be a central regulator of excitationcontraction coupling and a critical mediator of adrenergic signaling. 20 SR Ca 2ϩ leak is believed to be a possible mechanism for arrhythmias through I TI and DADs. CaMKIIoverexpressing mice display SR Ca 2ϩ leak and are more susceptible to arrhythmias. 20, 21 CaMKII is activated in a frequency-dependent manner, and increased CaMKII expression was found in AF. 14, 22 We hypothesized that increased CaMKII expression in AF leads to hyperphosphorylation of RyR2 at the CaMKII site, inducing SR Ca 2ϩ leak and increased diastolic [Ca 2ϩ ]. We further speculated that this could be normalized by CaMKII inhibition thus reducing proarrhythmogenic mechanisms in AF.
Methods

Human Samples
Right atrial appendages from patients with AF (nϭ20) and in sinus rhythm (nϭ27) were obtained during coronary artery bypass or cardiac valve surgery. All procedures were in compliance with the ethical committee of the institution. 
Cell Isolation
Measurement of Cell Dimensions
Cell dimensions were determined by obtaining 2D scans using the confocal microscope and measuring cell length and width. 
Measurements of
Patch-Clamp Investigation of L-type Ca 2؉ Current and Action Potentials
Patch-clamp experiments were performed using the EPC-10 amplifier and Patchmaster software (HEKA, Germany). The myocytes were placed in a recording chamber mounted on the stage of a microscope (Nikon). Both action potentials and I Ca were recorded using the ruptured-patch whole-cell-patch clamp technique. After rupture, 5 minutes was allowed for equilibration of intracellular solution and cytosol before starting recordings. Fast and slow capacitance as well as series resistance were compensated for using the built in functions of Patchmaster.
For action potential measurements, the bath solution contained (mmol/L): 135 NaCl, 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 HEPES, 0.33 NaH 2 PO 4 (23°C, pH 7.4, NaOH). Pipettes were pulled to resistances of 2 to 3 M⍀ when filled with intracellular solution consisting of (mmol/L): 120 K-aspartic acid, 8 KCL, 7 NaCl, 1 MgCl 2 , 5 MgATP, 10 HEPES (23°C, pH 7.2, Tris). A small holding current (Ͻ50 pA; on average 44.5Ϯ1.8 pA in AF and 38.3Ϯ5.1 in sinus rhythm; Pϭ0.3) was used to clamp cells to a diastolic potential of Ϫ75 mV and was kept constant in each myocyte. Action potentials were stimulated at 0.5 Hz and 2 Hz with 4-to 6-ms current pulses with a 40-to 60-pulse preconditioning train. From a holding potential of Ϫ70 mV, cells were briefly depolarized to Ϫ40 mV for 50 ms to inactivate Na ϩ currents, then clamped to test potentials steps between Ϫ30 mV and ϩ40 mV for a duration of 200 ms in 10 mV step increases with an interval of 1 s. Measured currents were normalized to membrane capacitance.
Western Blot Analysis
Atrial tissue samples were homogenized in Tris buffer containing (mmol/L): 20 Tris-HCl, 200 NaCl, 20 NaF, 1 Na 3 VO 4 , 1 DTT, 1% Triton X-100 (pH 7.4), and complete protease inhibitor cocktail (Roche Diagnostics). Protein concentration was determined by BCA assay (Pierce Biotechnology). Denatured tissue homogenates were subjected to Western blotting (4% to 15% gradient and 10% SDS-polyacrylamide gels) using anti-CaMKII (1:12000, gift from D. M. Bers, University of California, Davis, Calif) or anti-phosphoCaMKII (1:1000, Affinity Bioreagents), anti-RyR2 (1:2500), antiphospho-RyR2808 and 2814 (1:5000, all gifts from A. R. Marks, Columbia University, New York, NY), anti-NCX (1:5000, Swant), anti-SR Ca 2ϩ -ATPase (SERCA2a) (1:20000, Affinity Bioreagents), anti-PLB (1:10 000, Upstate), anti-phospho-Thr17 (1:1000, Badrilla) and anti-GAPDH (1:20 000, Biotrend Chemikalien) antibodies. Chemiluminescent detection was done with SuperSignal West Pico Substrate (Pierce).
Statistics
All data are presented as meansϮSEM. Statistical analyses were performed using Student t test for unpaired values, Fisher's exact test, or repeated-measures 2-way ANOVA, as appropriate. Values PϽ0.05 were considered significant. 
Results
Patient Characteristics
All patients in the AF group were in documented AF immediately before the operation. Patients did not show significant differences with respect to left ventricular function (50% to 60%), severe mitral valve insufficiency (10% to 11%), incidence of diabetes (25% to 41%), or pharmacological treatment received. Of note, none of them received antiarrhythmics.
Single Cell Dimensions
Single myocytes were measured to investigate possible cell hypertrophy. We found that cells from AF patients were 
CaMKII Expression and Phosphorylation Is Increased in AF
CaMKII expression and activation have previously been found to be increased in ventricular myocardium in human heart failure. 27 Our Western blot analysis showed significantly higher CaMKII protein levels in samples from AF patients as compared to those in sinus rhythm by 40Ϯ14% (AF, nϭ9; versus sinus rhythm, nϭ11; PϽ0.05; Figure 1b) . Similarly to CaMKII protein expression, phosphorylated 
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CaMKII (normalized to CaMKII protein expression) was significantly increased by 33Ϯ12% (AF, nϭ11; versus sinus rhythm, nϭ13; PϽ0.05; data not shown).
Expression Levels of RyR2, SERCA2a, and PLB
We further investigated possible changes in expression levels of Ca 2ϩ handling proteins. As shown in Figure 2a , we found significantly reduced expression of RyR2 by 445% (nϭ10 each; PϽ0.05). Whereas SERCA2a (AF, nϭ8; versus sinus rhythm, nϭ9) and PLB (nϭ8 versus nϭ9) expression levels were unaltered in AF compared to sinus rhythm patients (data not shown).
PLB Phosphorylation at the CaMKII Site Is Unaltered
To investigate possible effects of CaMKII on SERCA2a function, we measured phosphorylation of PLB (AF, nϭ8; versus sinus rhythm, nϭ9) at the CaMKII site (Thr17) as normalized to PLB expression and found that CaMKIIdependent PLB phosphorylation was unaltered in the AF patients investigated (87Ϯ20%; data not shown).
CaMKII-Dependent Phosphorylation of RyR2 Is Increased
RyR2 contains multiple phosphorylation sites including Ser2814, phosphorylated by CaMKII, and Ser2808, which may be phosphorylated by both CaMKII and protein kinase A. 14, 28 The degree to which phosphorylation of both sites induces "leakiness" of the channel is subject to debate, but recent results suggest a critical role of Ser2814. 15 RyR2 phosphorylation status at both sites was normalized to RyR2 protein levels. Phosphorylation levels of RyR2 were significantly increased by 110Ϯ53% at the CaMKII specific Ser2814 site (AF, nϭ9; versus sinus rhythm, nϭ10; PϽ0.05). At the Ser2808 site, phosphorylation was still increased by 29Ϯ14%, but this was not significant (nϭ9 versus nϭ10, Pϭ0.13; Figure 2b and (Figure 3a and 3b) .
Absolute free cytosolic Ca 2ϩ levels were investigated using Fura-2. We found that in the absence of CaMKII inhibition (KN-92), free cytosolic Ca 2ϩ levels were significantly increased in cells from AF patients as compared to sinus rhythm (229.4Ϯ19.6 versus 163.5Ϯ7.9 nmol/L, nϭ33 and nϭ43 for AF and sinus rhythm, PϽ0.05; Figure 3c ).
Ca
2؉ Sparks Are Not Attributable to Higher SR Ca 2؉ Load
Another reason for increased Ca 2ϩ spark frequency besides increased RyR2 phosphorylation could be a higher SR Ca 2ϩ load, which has been shown to provoke spontaneous SR Ca 2ϩ release ("leak-load relationship"). 29 To exclude this, we investigated SR Ca 2ϩ load. We found F/F 0 of the caffeine-induced transient to be significantly reduced in AF (2.68Ϯ0. 29 Figure 3b ), meaning a normalization to control levels in sinus rhythm. This CaMKII inhibition effect was still present, but with only a minor reduction of spark frequency in sinus rhythm to 88.7Ϯ19.5 pL Ϫ1 ⅐sec Ϫ1 (nϭ19, PϽ0.05). Spark size was not altered by CaMKII inhibition (Figure 3b) .
The net effect was a 4-fold reduction in total SR Ca 2ϩ leak in AF myocytes meaning a total normalization compared to sinus rhythm cells. In sinus rhythm myocytes, CaMKII inhibition had a much smaller but still significant reduction of SR Ca 2ϩ leak (Figure 3c ). Figure 3c ).
I Ca,L Is Not Reduced by CaMKII Inhibition in AF
CaMKII is known to be a regulator of L-type Ca 2ϩ channel function. 31 CaMKII inhibition has been shown to reduce I Ca,L in ventricular myocytes. 24, 31, 32 Whereas, in line with this, it has been demonstrated that CaMKII inhibition with KN-93 reduces I Ca,L in human right atrial cells from sinus rhythm patients, in contrast, it did not further reduce I Ca,L in AF cells. 33 To confirm these findings, we investigated I Ca,L in AF cells from our patients ( Figure 6 ) and found 
NCX Expression and Function in AF
NCX function has been reported to be increased in an animal model of AF. 30 We found that this was also true for human AF, as the decay of the caffeine-induced transients as estimated by their time constant tau showed a trend toward faster NCX Ca 2ϩ outward function in cells from AF patients, (1.71Ϯ0.12 sec versus 2.25Ϯ0.27 sec in sinus rhythm, nϭ18 versus nϭ21, Pϭ0.10). This correlated with significantly increased expression of NCX by 43Ϯ14% in AF as shown by Western blotting (nϭ5 versus nϭ6, PϽ0.05; Figure 7 ).
Action Potentials Are Shortened in AF
Shortening of APD is typical for electrophysiological remodeling in AF. To verify this in our samples, we investigated APD. As expected, 3 APD was shorter in AF samples. In particular, the later phase of repolarization was shorter in AF myocytes, whereas the very early phase was largely unaltered (Figure 8 ). This can also be seen in the mean data with an APD90 in AF of 179.5Ϯ21.8 ms at 0.5 Hz (nϭ7) and 144.4Ϯ14.6 ms at 2 Hz. In sinus rhythm myocytes, APD90 was significantly longer with 279.2Ϯ37.0 ms at (nϭ7) 0.5 Hz and 234.2Ϯ32.3 ms at 2 Hz (PϽ0.05). APD30, however, was not altered in AF compared to sinus rhythm (Pϭ0.5 and Pϭ0.8).
Discussion
The results of the present study show that AF leads to elevated diastolic Ca 2ϩ levels in human atrial myocytes and demonstrate that CaMKII may be central to this disordered Ca 2ϩ -homeostasis: Molecular and functional data show consistently that CaMKII-dependent hyperphosphorylation of the RyR2 leads to elevated SR Ca 2ϩ leak and increased diastolic [Ca 2ϩ ] in human AF. These effects could be reversed by CaMKII inhibition and by closing the SR Ca 2ϩ leak with tetracaine.
Altered Ca 2؉ Handling in AF
In AF, there is electric and contractile remodeling of the myocardium. Abnormalities in intracellular Ca 2ϩ handling are believed to contribute to atrial arrhythmogenesis during AF. Although it has been speculated that diastolic [Ca 2ϩ ] might be elevated in AF, 34 this has never been investigated in human myocytes.
One important mechanism that can lead to elevated diastolic [Ca 2ϩ ] levels is Ca 2ϩ leak from the SR via the RyR2. In fact, Hove-Madsen et al have shown increased SR Ca 2ϩ sparks in human AF. 12 However, the cause for this and whether it Figure 5 . Tetracaine abolishes the occurrence of Ca 2؉ sparks and normalizes diastolic Ca 2؉ concentration. Twelve of 19 cells from sinus rhythm patients investigated showed sparks without tetracaine, with tetracaine none of 21 cells showed sparks. In cells from AF patients, there were sparks in 7 of 16 cells without tetracaine, but none of 14 cells showed sparks with tetracaine. Diastolic Ca 2ϩ in AF cells in NT solution (nϭ16 from 2 patients) was normalized down to sinus rhythm levels by tetracaine (nϭ22). Whereas in cells from sinus rhythm patients, tetracaine (nϭ16) had no effect on Ca 2ϩ levels compared to NT (nϭ15 from 2 patients). ] remained unknown. Increased RyR2 open probability has been shown in an animal model of AF and in human samples, 13 suggesting that direct regulation of the channel (eg, by phosphorylation through protein kinase A) might play a role. Recent reports provided evidence that CaMKII is associated with RyR2 and that it can phosphorylate the receptor. 15 ]. Although we found RyR2 expression to be reduced in AF (which could be expected to lead to reduced SR Ca 2ϩ leak), we found that the RyR2 is more phosphorylated. Most importantly, we saw strong hyperphosphorylation of the RyR2 at the CaMKII specific site, which correlates with the increased CaMKII expression we found in AF (in accordance with previous studies) 22 as well as the increased CaMKII autophosphorylation (activation) that has recently been demonstrated in AF. 41 Phosphorylation of the RyR2 at this site is increasingly being believed to be the critical mechanism inducing diastolic SR Ca 2ϩ leak in failing ventricular myocardium. But does it have the same consequences in atrial myocytes as well?
In fact, our studies showed that the SR Ca 2ϩ leak, as measured by the frequency and size of Ca 2ϩ sparks, was strongly increased in cells from AF patients. Increased SR Ca 2ϩ content might have been a trigger for the increased SR Ca 2ϩ leak observed by us. However, we could confirm previous findings that SR Ca 2ϩ content is not increased in AF, 12, 18, 30 which corroborates our hypothesis that hyperphosphorylation of the RyR2 is the cause for this increased leak. This is further 
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strengthened by our observation that in the presence of CaMKII inhibition, SR Ca 2ϩ leak was completely normalized in AF cells and that in addition, CaMKII inhibition also lead to a normalization of diastolic [Ca 2ϩ ] to levels seen in cells from sinus rhythm patients. On the other hand, in cells from sinus rhythm patients where SR Ca 2ϩ leak is already low, CaMKII inhibition did not lead to a further reduction of cytosolic free Ca 2ϩ . To exclude the possibility that a reduction of I Ca,L attributable to CaMKII inhibition rather than the reduction of SR Ca 2ϩ leak was the cause for these effects, we investigated the effect of CaMKII inhibition on I Ca,L . Our results confirm previous findings that in human AF, 33 in contrast to sinus rhythm, CaMKII inhibition does not further reduce the already diminished I Ca,L . This further strengthens our hypothesis that CaMKII-mediated SR Ca 2ϩ leak was the main cause of elevated cytosolic Ca 2ϩ levels in AF. Furthermore we as well as others found NCX function to be slightly increased in human AF in the presence of significantly increased NCX expression. 30 We suggest that this might be a compensatory mechanism in the face of the elevated diastolic Ca 2ϩ levels.
CaMKII-Dependent SR Ca 2؉ Leak As Potential Arrhythmogenic Substrate
Increased SR Ca 2ϩ leak is regarded as a potential arrhythmogenic mechanism, because elimination of Ca 2ϩ via the NCX would lead to depolarization of the cell and I TI , which could cause DADs as shown previously by Song et al in ventricular guinea pig myocytes. 42 Also, experiments in dog pulmonary veins have already demonstrated that ectopy may result from Ca 2ϩ -mediated triggered activity arising from DADs. 43 Moreover, transgenic mice with increased SR Ca 2ϩ leak attributable to FKBP12.6 deficiency have been shown to be more prone to induced AF. 44 Also, mice overexpressing CaMKII␦ display an increased propensity to arrhythmias 21 ; whether they also develop AF is not known. Furthermore, very recent findings by Chelu et al from elegant studies in knock-in mice with a RyR2 which is not phosphorylatable by CaMKII suggest that CaMKII SR Ca 2ϩ leak through the RyR2 might be relevant for AF induction. 41 Consequently, we suggest that CaMKII-dependent SR Ca 2ϩ leak in AF caused by hyperphosphorylation of the RyR2 could be an arrhythmogenic mechanism and that CaMKII inhibition may reduce the propensity for atrial arrhythmias and might provide a novel therapeutic target.
CaMKII Inhibition Targets SR Ca
2؉ Leak but Not I Ca,L in AF That CaMKII inhibition does not further decrease I Ca,L in AF is also important with respect to potential therapeutic use; importantly, it means that CaMKII inhibition can target one arrhythmogenic mechanism (SR Ca 2ϩ leak) while not further aggravating another (reduced APD attributable to reduced I Ca,L ). Although these differential effects of CaMKII inhibition on I Ca,L in AF versus sinus rhythm are quite surprising at first, they can be explained by findings by El-Armouche et al, which suggest that in AF, PP activity becomes differentially regulated in subcellular compartments: whereas PP1 activity is suppressed around the SR, PP1 and PP2a activity are increased at the cell membrane. This means that in AF CaMKII effects would be on one hand amplified around the SR, where the RyR2 is located, they would on the other hand be suppressed at the cell membrane, where the L-type Ca 2ϩ channel is located. Thus, CaMKII inhibition can rather specifically target SR Ca 2ϩ leak while not having significant effects on I Ca,L .
Limitations of the Study
It has to be mentioned that for the in vivo data, differences in heart rate might have played a role with respect to CaMKIIeffects, because CaMKII can be activated in a frequency dependent manner. 15 However, for our in vitro data, such a confounder can be ruled out, as myocytes from both groups were stimulated at the same frequencies. Therefore, we may rather have underestimated CaMKII-dependent effects in AF cells by performing experiments using the same stimulation rates in AF as well as sinus rhythm.
Because of the methodology of Ca 2ϩ sparks, only those cells could be analyzed for SR Ca 2ϩ leak that showed any Ca 2ϩ sparks. However, one effect of CaMKII inhibition was that the percentage of cells that actually showed Ca 2ϩ sparks was considerably reduced. This means that the real effect of CaMKII inhibition on SR Ca 2ϩ leak in AF will probably be even stronger than what is already presented in our investigation.
Summary and Perspectives
We present data showing that CaMKII-dependent phosphorylation of the RyR2 leads to increased SR Ca 2ϩ leak in AF. This causes elevated cytosolic Ca 2ϩ levels, which might provide an arrhythmogenic substrate. Consequently, CaMKII inhibition should be investigated with respect to it possibly providing novel antiarrhythmogenic strategies and therapies in AF. With respect to established pharmacological treatments in AF, our results might explain a part of the antiarrhythmic effect of ␤-blockers, which work upstream of CaMKII and which have been shown to reduce hyperphosphorylation of the RyR2 and reduce SR Ca 2ϩ leak. 45, 46 Sources of Funding 
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Novelty and Significance
What Is Known?
• Ca 2ϩ leak (Ca 2ϩ sparks) is increased in human AF.
• CaMKII activity is increased in AF.
• Protein phosphatase activity at the SR is decreased in AF.
What New Information Does This Article Contribute?
• Diastolic Ca 2ϩ concentration is increased in human AF.
• CaMKII inhibition can normalize increased Ca 2ϩ spark frequency and diastolic Ca 2ϩ concentration; this is not attributable to effects on I Ca,L or SR Ca 2ϩ load, but to effects on the RyR2.
• CaMKII-mediated SR Ca 2ϩ leak appears to be a novel arrhythmogenic mechanism in AF; its inhibition could be a therapeutic strategy.
Sarcoplasmic reticulum (SR) Ca 2ϩ leak and elevated diastolic Ca 2ϩ are emerging as possible important arrhythmogenic mechanisms and therapeutic targets in the heart. In atrial fibrillation (AF), increased SR Ca 2ϩ leak (Ca 2ϩ sparks) has previously been reported, but its mechanisms are unknown and diastolic Ca 2ϩ has not been investigated. In this study of human AF, we show that SR Ca 2ϩ leak is attributable to CaMKIIdependent hyperphosphorylation of the SR Ca 2ϩ release channel (RyR2) and that this leads to elevation of diastolic Ca 2ϩ . CaMKII inhibition can normalize both SR Ca 2ϩ leak and diastolic Ca 2ϩ levels. Because CaMKII inhibition does not further reduce the already diminished L-type Ca 2ϩ current in AF, it might provide a novel, specifically targeted antiarrhythmic strategy in AF that should be investigated in the future. Furthermore, AF and heart failure are often associated and can aggravate each other. CaMKII-dependent pathophysiological mechanisms have been proposed as therapeutic targets for hypertrophy and heart failure. Our results suggest that CaMKII inhibition could be beneficial with respect to AF, as well as heart failure, thus offering a novel combined therapeutic approach for these two conditions.
